Tendersinfo Gulf

Filter Search

Europe

Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Vildagliptin (atc Code 2026-09-27
Bulgaria Dynamic System For Purchases Of Medicinal Products For The Needs Of "mbalsvoge" Llc For A Period Of 2 Years 2026-09-28
Lithuania Natural Gas Orders Through Cpo Lt Electronic Catalog 2026-09-28
Germany Medicines Containing The Active Ingredient Bosutinib (atc 2026-09-30
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Social Security Code V For Medicinal Products Containing The Active Ingredient Ertugliflozin (a10bk04) Within The Framework Of A So-called Open House Mod 2026-09-30
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Social Security Code V For Medicinal Products Containing The Active Ingredient Vildagliptin (a10bh02) Within The Framework Of A So-called Open House Mode 2026-09-30
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Brinzolamide And Brimonidine (s01ec24) Within The Framework Of A So-called Open House Mod 2026-09-30
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Social Security Code V For Medicinal Products Containing The Active Ingredients Dienogest And Estrogen (g03fa15) Within The Framework Of A So-called Open 2026-09-30
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Iron(iii) Sodium Gluconate Complex (b03ac07) Within The Framework Of A So-called Open Hous 2026-09-30
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Paliperidone (n05ax13) And The Trade Name Trevicta® Within The Framework Of A So-called Op 2026-09-30
Whats app